JPTCCM
BLUE

J.P. Turner & Co Capital Management’s bluebird bio BLUE Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-141
Closed -$310K – 190
2015
Q2 		$310K Buy
+141
New +$287K 0.24% 141

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

J.P. Turner & Co Capital Management's BLUE Position: Q3 2015 in Review

J.P. Turner & Co Capital Management sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 141 shares — an estimated $310K sold.

J.P. Turner & Co Capital Management first reported a position in BLUE in Q2 2015 and held it in 1 quarter. The position peaked at $310K in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

  • J.P. Turner & Co Capital Management reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
  • J.P. Turner & Co Capital Management sold 141 bluebird bio shares in Q3 2015, an estimated $310K.
  • J.P. Turner & Co Capital Management first reported a position in bluebird bio in Q2 2015 and held it in 1 quarter.
  • J.P. Turner & Co Capital Management's bluebird bio position peaked at $310K in Q2 2015.
  • 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.